Medical Patent Law – The Challenges of Medical Treatment

Medical Patent Law – The Challenges of Medical Treatment

Eddy D. Ventose

This book provides a detailed and comparative examination of medical patent law and the issues at the heart of the medical treatment exclusion for therapeutic treatments, surgical treatments and diagnostic methods.

Chapter 2: Arguments for Patent Protection

Eddy D. Ventose

Subjects: law - academic, biotechnology and pharmaceutical law, health law, intellectual property law


A INTRODUCTION The importance of public health to a country’s welfare and economy is such that governments usually spend considerable amounts of money in ensuring that there is an adequate supply of medical services and that medical research continues unabated.1 Ensuring that public health is not unnecessarily compromised by patent law should, therefore, be a legitimate goal of government. According to Dworkin, it is competent for governments to pursue arguments in favour of public health and to adopt programs and strategies that are generated by such arguments.2 But, before any government can make an informed decision either way on the patentability of methods of medical treatment, it should ensure that there is sufficient evidence of the impact that they have on public health. It must also ensure that due consideration is given to the types of arguments that will be considered in this chapter.3 There was no major debate in Europe when the methods of medical treatment were excluded from patent protection under the European Patent Convention (EPC) in 1973. However, in the United States, the Medical Procedures and Affordability Act 1996 (MPAA) was preceded by a significant amount of debate both inside and outside Congress.4 The main arguments for patenting methods of medical treatment are based on various rationales that have been used to explain the patent system: namely, the incentive to disclose; the incentive to invent/innovate; the prospect 1 For example, in the United States, $488.8 billion was allocated to the Department of Health and Human...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information